Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

Cyrus Cooper, Thomas Bardin, Maria-Luisa Brandi, Patrice Cacoub, John Caminis, Roberto Civitelli, Maurizio Cutolo, Willard Dere, Jean-Pierre Devogelaer, Adolfo Diez-Perez, Thomas A. Einhorn, Patrick Emonts, Olivier Ethgen, John A. Kanis, Jean-Marc Kaufman, Tore K. Kvien, Willem F. Lems, Eugene McCloskey, Pierre Miossec, Susanne ReiterJohann Ringe, Rene Rizzoli, Kenneth Saag, Jean-Yves Reginster

Research output: Contribution to journalArticleAcademic

21 Citations (Scopus)
Original languageEnglish
Pages (from-to)1-16
JournalAging - Clinical and Experimental Research
Issue number1
Publication statusPublished - Feb 2016


  • Cohort studies
  • Glucocorticoids
  • Inflammation
  • Osteoporosis
  • Rheumatic diseases
  • Rheumatoid arthritis

Cite this